To DOAC or Not to DOAC for Left Ventricular Thrombi-What Is the Dose?
JAMA Cardiol
.
2021 May 1;6(5):603-604.
doi: 10.1001/jamacardio.2020.6894.
Authors
Arun Manmadhan
1
,
Jeffrey S Berger
2
,
Tania Ahuja
3
Affiliations
1
Leon H. Charney Division of Cardiology, NYU Langone Health/Bellevue Hospital/Manhattan VA Hospital, New York, New York.
2
Center for the Prevention of Cardiovascular Disease, New York University School of Medicine, NYU Langone Health, New York.
3
Department of Pharmacy, NYU Langone Health, New York, New York.
PMID:
33471023
DOI:
10.1001/jamacardio.2020.6894
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / therapeutic use
Humans
Thrombosis* / drug therapy
Substances
Anticoagulants